Kiyofuji S.; Perry A.; Graffeo C.S.; Giannini C.; Link M.J., The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature, «PITUITARY», 2018, 21, pp. 231 - 237 [Scientific article]
Sahm F.; Reuss D.E.; Giannini C., WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours, «NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY», 2018, 44, pp. 163 - 171 [Scientific article]
Pekmezci M.; Rice T.; Molinaro A.M.; Walsh K.M.; Decker P.A.; Hansen H.; Sicotte H.; Kollmeyer T.M.; McCoy L.S.; Sarkar G.; Perry A.; Giannini C.; Tihan T.; Berger M.S.; Wiemels J.L.; Bracci P.M.; Eckel-Passow J.E.; Lachance D.H.; Clarke J.; Taylor J.W.; Luks T.; Wiencke J.K.; Jenkins R.B.; Wrensch M.R., Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT, «ACTA NEUROPATHOLOGICA», 2017, 133, pp. 1001 - 1016 [Scientific article]Open Access
Prasad N.K.; Tubbs R.S.; Amrami K.K.; Dyck P.J.B.; Mauermann M.L.; Giannini C.; De Divitiis O.; Spinner R.J., Can intraneural perineuriomas occur intradurally? An anatomic perspective, «NEUROSURGERY», 2017, 80, pp. 226 - 234 [Scientific article]
Korfel A.; Schlegel U.; Johnson D.R.; Kaufmann T.J.; Giannini C.; Hirose T., Case-based review: Primary central nervous system lymphoma, «NEURO ONCOLOGY PRACTICE», 2017, 4, pp. 46 - 59 [Scientific article]
Johnson D.R.; Diehn F.E.; Giannini C.; Jenkins R.B.; Jenkins S.M.; Parney I.F.; Kaufmann T.J., Genetically defined oligodendroglioma is characterized by indistinct tumor borders at MRI, «AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY», 2017, 38, pp. 678 - 684 [Scientific article]
Shankar G.M.; Abedalthagafi M.; Vaubel R.A.; Merrill P.H.; Nayyar N.; Gill C.M.; Brewster R.; Bi W.L.; Agarwalla P.K.; Thorner A.R.; Reardon D.A.; Al-Mefty O.; Wen P.Y.; Alexander B.M.; Van Hummelen P.; Batchelor T.T.; Ligon K.L.; Ligon A.H.; Meyerson M.; Dunn I.F.; Beroukhim R.; Louis D.N.; Perry A.; Carter S.L.; Giannini C.; Curry W.T.; Cahill D.P.; Barker F.G.; Brastianos P.K.; Santagata S., Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas, «NEURO-ONCOLOGY», 2017, 19, pp. 535 - 545 [Scientific article]
Cavalli F.M.G.; Remke M.; Rampasek L.; Peacock J.; Shih D.J.H.; Luu B.; Garzia L.; Torchia J.; Nor C.; Morrissy A.S.; Agnihotri S.; Thompson Y.Y.; Kuzan-Fischer C.M.; Farooq H.; Isaev K.; Daniels C.; Cho B.-K.; Kim S.-K.; Wang K.-C.; Lee J.Y.; Grajkowska W.A.; Perek-Polnik M.; Vasiljevic A.; Faure-Conter C.; Jouvet A.; Giannini C.; Nageswara Rao A.A.; Li K.K.W.; Ng H.-K.; Eberhart C.G.; Pollack I.F.; Hamilton R.L.; Gillespie G.Y.; Olson J.M.; Leary S.; Weiss W.A.; Lach B.; Chambless L.B.; Thompson R.C.; Cooper M.K.; Vibhakar R.; Hauser P.; van Veelen M.-L.C.; Kros J.M.; French P.J.; Ra Y.S.; Kumabe T.; Lopez-Aguilar E.; Zitterbart K.; Sterba J.; Finocchiaro G.; Massimino M.; Van Meir E.G.; Osuka S.; Shofuda T.; Klekner A.; Zollo M.; Leonard J.R.; Rubin J.B.; Jabado N.; Albrecht S.; Mora J.; Van Meter T.E.; Jung S.; Moore A.S.; Hallahan A.R.; Chan J.A.; Tirapelli D.P.C.; Carlotti C.G.; Fouladi M.; Pimentel J.; Faria C.C.; Saad A.G.; Massimi L.; Liau L.M.; Wheeler H.; Nakamura H.; Elbabaa S.K.; Perezpena-Diazconti M.; Chico Ponce de Leon F.; Robinson S.; Zapotocky M.; Lassaletta A.; Huang A.; Hawkins C.E.; Tabori U.; Bouffet E.; Bartels U.; Dirks P.B.; Rutka J.T.; Bader G.D.; Reimand J.; Goldenberg A.; Ramaswamy V.; Taylor M.D., Intertumoral Heterogeneity within Medulloblastoma Subgroups, «CANCER CELL», 2017, 31, pp. 737 - 754.e6 [Scientific article]Open Access
Buckner J.; Giannini C.; Eckel-Passow J.; Lachance D.; Parney I.; Laack N.; Jenkins R., Management of diffuse low-grade gliomas in adults - Use of molecular diagnostics, «NATURE REVIEWS. NEUROLOGY», 2017, 13, pp. 340 - 351 [Scientific article]
Brown P.D.; Ballman K.V.; Cerhan J.H.; Anderson S.K.; Carrero X.W.; Whitton A.C.; Greenspoon J.; Parney I.F.; Laack N.N.I.; Ashman J.B.; Bahary J.-P.; Hadjipanayis C.G.; Urbanic J.J.; Barker F.G.; Farace E.; Khuntia D.; Giannini C.; Buckner J.C.; Galanis E.; Roberge D., Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, «THE LANCET ONCOLOGY», 2017, 18, pp. 1049 - 1060 [Scientific article]Open Access
Ida C.M.; Butz M.L.; Jenkins R.B.; Sarkaria J.N.; Kitange G.J.; Giannini C.; Kipp B.R., Real-time methylation-specific polymerase chain reaction for MGMT promoter methylation clinical testing in glioblastoma an alternative detection method for a heterogeneous process, «AMERICAN JOURNAL OF CLINICAL PATHOLOGY», 2017, 148, pp. 296 - 307 [Scientific article]
Graffeo C.S.; Leeper H.E.; Perry A.; Uhm J.H.; Lachance D.J.; Brown P.D.; Ma D.J.; Van Gompel J.J.; Giannini C.; Johnson D.R.; Raghunathan A., Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma, «WORLD NEUROSURGERY», 2017, 103, pp. 655 - 663 [Scientific article]
Peacock J.G.; Harmsen W.S.; Link M.J.; Van Gompel J.J.; Giannini C.; Olsen K.D.; Garces Y.I.; Neben Wittich M.A.; Ma D.J.; Park S.S.; Foote R.L., Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma, «JOURNAL OF NEUROLOGICAL SURGERY. PART B, SKULL BASE», 2017, 78, pp. 68 - 74 [Scientific article]
Vaubel R.A.; Kollmeyer T.M.; Caron A.A.; Barr Fritcher E.G.; Voss J.S.; Liang H.; Jenkins R.B.; Giannini C.; Kipp B.R., Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism, «ACTA NEUROPATHOLOGICA», 2017, 134, pp. 317 - 319 [Comment or similar]
Graffeo C.S.; Perry A.; Copeland W.R.; Giannini C.; Neff B.A.; Driscoll C.L.W.; Link M.J., Synchronous Tumors of the Cerebellopontine Angle, «WORLD NEUROSURGERY», 2017, 98, pp. 632 - 643 [Scientific article]
